Browse > Article
http://dx.doi.org/10.4333/KPS.2009.39.4.269

Preparation and Dissolution Characteristics of A Gastro-Retentive Tablet System Containing Gabapentin  

You, Kwang-Hee (R&D Center, Kuhnil Pharm. Co., Ltd.)
Lee, Pung-Sok (R&D Center, Kuhnil Pharm. Co., Ltd.)
Oh, Eui-Chaul (Seoul National University, STH Pharm, Inc.)
Publication Information
Journal of Pharmaceutical Investigation / v.39, no.4, 2009 , pp. 269-273 More about this Journal
Abstract
The objective of this investigation was to develop a gastro-retentive(GR) dosage form of gabapentin and was to evaluate of its dissolution characteristics. GR tablet consists of expandable core tablet matrix and semi-permeable membrane coating. Poloxamer 407 and sodium bicarbonate were used to prepare the core matrix. Polyvinly acetate dispersion (Kollicoat $SR30D^{(R)}$) and polyvinyl alcohol-polyethylene glycol copolymer ((Kollicoat $IR^{(R)}$)) were employed to form the semi-permeable membrane. The GR tablets significantly expanded up to fivefold in simulated gastrointestinal fluids with no apparent damage of the coating membrane over 12 hours. Also, the swelling rate was controllable with the amount of sodium bicarbonate. The drug release was observed to be substantially sustained based on coating level. The release rate of gabapentin from the GR tablet was gradually slowed down as the coasting amount was increased. The gabapentin GR tablet with 8% coating level showed a pseudo-zero order release kinetics over 12 hours. These results suggest that this swellable GR tablet system having semi-permeable membrane coating can be applicable for hydrophilic drug substances like gabapentin.
Keywords
Gabapentin; Gastro-retentive tablet; Semi-permeable membrane;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 E.A. Klausner, S. Eyal, E. Lavy, M. Friedman and A. Hoffmana, Novel levodopa gastroretentive dosage form: invivo evaluation in dogs, J.Control. Release, 88, 117–126 (2003).   DOI   ScienceOn
2 L. Meka, B. Kesavan, K.M. Chinnala, V. Vobalaboina, and M.R. Yamsanil, Preparation of a matrix type multiple-unit gastro retentive floating drug delivery system for captopril based on gas formation technique: In vitro evaluation, AAPS PharmSciTech, 9(2), 612-618 (2008).   DOI   ScienceOn
3 M. Oth, M. Franz, J. Timmermans and A. Moes, The bilayer floating capsule: a stomach-directed drug delivery system for misoprostol. Pharm. Res. 9, 298-302 (1992)   DOI   ScienceOn
4 T. Gordi, E. Hou, S. Kasichayanula and B. Berner, Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive?extended-release and immediate-release tablets: A randomized, open-label, multiple-dose, tree-way crossover, exploratory study in healthy subjects, Clinical Therapeutics, 30(5), 909-916 (2008).   DOI   ScienceOn
5 A.A. Deshpande, C.T. Rhodes, N.H. Shah and A.W. Malick, Controlled-release drug delivery systems for prolonged gastric residence, Drug Dev. Ind. Pharm., 22(6), 531-539 (1996).   DOI   ScienceOn
6 A. Streuble, J. Siepmann and R. Bodmeier, Gastroretentive drug delivery systems, Expert Opin. Drug Deliv., 3(2), 217- 233 (2006)   DOI   ScienceOn
7 Y.D. Tang, S.S. Venkatraman, F.Y.C. Boey and L.W. Wang, Sustained release of hydrophobic and hydrophilic drugs from a floating dosage form, J. Pharmaceutics, 336, 159- 165 (2007).   DOI   ScienceOn
8 S. Frances, T.F. John, H.C. John, G.M. Luigi, L.S. Harbrans and S. Anne-marie, The use of citric acid to prolong the in vivo gastro retention of floating dosage form in the fasted state, Int. J. Pharmaceutics, 308, 8-13 (2006).   DOI   ScienceOn
9 H.Y. Cho, H.A. Kang, E.J. Park, S.W. Oh, J.D. Moon and Y.B. Lee, Bioequivalence of Kuhnil Gabapentin capsule 300 mg to Neurontin capsule 300 mg (gabapentin 300mg), J. Kor. Pharm. Sci., 35(3), 193-199 (2005).   과학기술학회마을   DOI   ScienceOn
10 A. Amin, T. Shah, D. Parikh and M Shah, Progress in swellable & low density excipients for prolonged gastric retention, Drug Delivery Tech., (Feb), 22-26 (2008).
11 T. Gordi, V. Cowles, Y.K. Chiang and E. Hou, Gabapentin pharmacokinetics after the administration of a gastric retentive formulation in postmenopausal women with hot flashes, Abstracts No. 1839, AAPS Annual Meeting, (2008).
12 V. Cowles, G. Gusler, R. Gu, J. Louie-Helm, E. Hou and B. Berner, Dose Proportionality of Gabapentin Gastric Retentive Extended-Release Tablets in Beagle Dog, Abstracts No. 2109, AAPS Annual Meeting, (2006).
13 M. Chavanpatil, P. Jain, S. Chaudhari, R. Shear and P. Vavia, Development of sustained release gastroretentive drug delivery system for ofloxacin: In vitro and in vivo evaluation, Int. J. Pharm. 304, 178-184 (2005).   DOI   ScienceOn
14 B.N. Singh and H.N. Kim, Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention, J. Control. Release, 63, 235-259 (2000).   DOI   ScienceOn
15 S.S. Ahmed and J.W. Ayres, Bioavailability of riboflavin from a gastric retention formulation, Int. J. Pharmaceutics, 330, 146-154 (2007).   DOI   ScienceOn
16 E.A. Klausner, E. Lavy, M. Friedman, A. Hoffman, Expandable gastroretentive dosage form, J. Control. Release, 90, 142-162 (2003).   DOI   ScienceOn